Active: Neuropsychopharmacology Clear all

GWAS 2022-01-29

Genome-wide meta-analysis of alcohol use disorder in East Asians.

Zhou H, Kalayasiri R et al.

Neuropsychopharmacology

Alcohol use disorder (AUD) is a leading cause of death and disability worldwide. Genome-wide associa...

Alcohol use disorder

13551

Participants

N/A

Studies

Details PubMed

GWAS 2021-05-30

Genetic underpinnings of sociability in the general population.

Bralten J, Mota NR et al.

Neuropsychopharmacology

Levels of sociability are continuously distributed in the general population, and decreased sociabil...

Sociability score

342461

Participants

N/A

Studies

Details PubMed

GWAS 2020-04-12

Shared genetic background between children and adults with attention deficit/hyperactivity disorder.

Rovira P, Demontis D et al.

Neuropsychopharmacology

Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterize...

Attention deficit hyperactivity disorder

49560

Participants

N/A

Studies

Details PubMed

GWAS 2020-01-11

Polygenic prediction and GWAS of depression, PTSD, and suicidal ideation/self-harm in a Peruvian cohort.

Shen H, Gelaye B et al.

Neuropsychopharmacology

Genome-wide approaches including polygenic risk scores (PRSs) are now widely used in medical researc...

Depression

3404

Participants

N/A

Studies

Details PubMed

GWAS 2019-09-02

Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population.

Otsuka I, Akiyama M et al.

Neuropsychopharmacology

Suicide is a significant public health problem worldwide, and several Asian countries including Japa...

Age at suicide

719

Participants

N/A

Studies

Details PubMed

GWAS 2019-08-29

Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2.

Luo A, Jung J et al.

Neuropsychopharmacology

To investigate the potential role of alcohol use disorder (AUD) in aging processes, we employed Levi...

Epigenetic age acceleration in alcohol use disorder

310

Participants

N/A

Studies

Details PubMed

GWAS 2018-04-27

Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder.

Li X, Luo Z et al.

Neuropsychopharmacology

Accumulating evidence suggests that genetic factors have a role in major depressive disorder (MDD). ...

Major depressive disorder

Replicated

356649

Participants

N/A

Studies

Details PubMed

GWAS 2016-09-15

Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation.

Gao J, Davis LK et al.

Neuropsychopharmacology

Loneliness is a complex biological trait that has been associated with numerous negative health outc...

Loneliness (multivariate analysis)

10760

Participants

N/A

Studies

Details PubMed

GWAS 2016-08-17

The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene.

Polimanti R, Wang Q et al.

Neuropsychopharmacology

To identify genetic mechanisms involved in the interplay of risky sexual behaviors (RSBs) and alcoho...

Risky sexual behaviors (alcohol dependence interaction)

3924

Participants

N/A

Studies

Details PubMed

GWAS 2014-10-06

Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder.

Sánchez-Mora C, Ramos-Quiroga JA et al.

Neuropsychopharmacology

Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder with high heritabil...

Persistent attention-deficit hyperactivity disorder

Replicated

5196

Participants

N/A

Studies

Details PubMed

GWAS 2013-04-17

Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Ikeda M, Okahisa Y et al.

Neuropsychopharmacology

Methamphetamine (METH) use can provoke psychotic reactions requiring immediate treatment, namely MET...

Psychosis (methamphetamine induced)

234

Participants

N/A

Studies

Details PubMed

GWAS 2011-10-26

Genome-wide association study of antidepressant treatment-emergent suicidal ideation.

Menke A, Domschke K et al.

Neuropsychopharmacology

Emergence of suicidal ideation (TESI) during treatment with antidepressants in major depression led ...

Suicidal ideation

Replicated

898

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Genome-wide meta-analysis of alcohol use disorder in East Asians.

Zhou H, Kalayasiri R et al.

Neuropsychopharmacology

Alcohol use disorder

2022-01-29

Genetic underpinnings of sociability in the general population.

Bralten J, Mota NR et al.

Neuropsychopharmacology

Sociability score

2021-05-30

Shared genetic background between children and adults with attention deficit/hyperactivity disorder.

Rovira P, Demontis D et al.

Neuropsychopharmacology

Attention deficit hyperactivity disorder

2020-04-12

Polygenic prediction and GWAS of depression, PTSD, and suicidal ideation/self-harm in a Peruvian cohort.

Shen H, Gelaye B et al.

Neuropsychopharmacology

Depression

2020-01-11

Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population.

Otsuka I, Akiyama M et al.

Neuropsychopharmacology

Age at suicide

2019-09-02

Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2.

Luo A, Jung J et al.

Neuropsychopharmacology

Epigenetic age acceleration in alcohol use disorder

2019-08-29

Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder.

Li X, Luo Z et al.

Neuropsychopharmacology

Major depressive disorder

2018-04-27

Genome-Wide Association Study of Loneliness Demonstrates a Role for Common Variation.

Gao J, Davis LK et al.

Neuropsychopharmacology

Loneliness (multivariate analysis)

2016-09-15

The Interplay Between Risky Sexual Behaviors and Alcohol Dependence: Genome-Wide Association and Neuroimaging Support for LHPP as a Risk Gene.

Polimanti R, Wang Q et al.

Neuropsychopharmacology

Risky sexual behaviors (alcohol dependence interaction)

2016-08-17

Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder.

Sánchez-Mora C, Ramos-Quiroga JA et al.

Neuropsychopharmacology

Persistent attention-deficit hyperactivity disorder

2014-10-06

Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.

Ikeda M, Okahisa Y et al.

Neuropsychopharmacology

Psychosis (methamphetamine induced)

2013-04-17

Genome-wide association study of antidepressant treatment-emergent suicidal ideation.

Menke A, Domschke K et al.

Neuropsychopharmacology

Suicidal ideation

2011-10-26